OCT4 antibody and lineage transcription factor reagents that survive the protocol

Getting nuclear stains to work

1. Extract the nucleus, do not lyse the cell. A standard whole cell buffer leaves much of a chromatin bound factor in the pellet. A nuclear extraction protocol, with the pellet checked, is what puts these targets on a blot.
2. Optimise retrieval per reagent in tissue. Nuclear epitopes in cross linked tissue almost always need retrieval, and the optimal buffer and duration differ between reagents. Optimise on tissue known to be positive.
3. Separate identity from immediate early activity. Several factors here are induced within minutes of any stimulus, including handling. Treating them as lineage markers produces conclusions about identity from what is actually a stress response.
4. Score nuclear localisation, not intensity alone. For factors that shuttle, the informative measurement is the proportion in the nucleus per cell. Whole field intensity mixes that with expression level.
5. Include a known positive population. A tissue or cell line known to express the factor, on the same slide or blot, is what makes a negative result credible and a weak result interpretable.

An OCT-4 antibody target is low in abundance and tightly bound

Transcription factors are present at a small fraction of the abundance of structural proteins and are held in complexes on DNA. Both properties work against detection, and both are addressed by extraction rather than by a more sensitive reagent.

Check the pellet once, on a positive control, and the extraction question is settled for every subsequent experiment in that cell type.

Handling induces some of these markers

Dissociation, medium change and even a few minutes at room temperature induce immediate early factors. In any experiment where one arm is processed differently from another, that becomes a group difference.

Randomise processing across groups, keep the interval fixed, and record it. It is the same discipline that protects phosphorylation work, applied to transcription.

An insm1 antibody and the neuroendocrine reading

INSM1 is a nuclear transcription factor used in pathology as a neuroendocrine marker, and because it is nuclear rather than cytoplasmic the pattern itself is part of the validation. An insm1 antibody needs a tissue known to carry the lineage on the same slide, since the marker is judged by the proportion of nuclei stained. Retrieval conditions decide whether a nuclear antigen is reached at all.

An sp1 antibody and a factor present in every cell

SP1 is ubiquitous, so an sp1 antibody almost never reports a presence or absence and is used instead for occupancy at a promoter, for a pulldown or as a nuclear loading reference. It is heavily modified, so apparent mass moves and several bands are expected rather than one. For chromatin work the clone has to be validated in that application, since a denatured blot predicts nothing about crosslinked chromatin.

A tead1 antibody and the pathway it is the output of

TEAD factors are the transcriptional partners of the Hippo pathway effectors, and their own level changes little while their partner's location changes a lot. A tead1 antibody is therefore read beside a YAP stain and a fractionation rather than alone. The family members share a DNA binding domain, so cross reactivity data and the immunogen position are the two lines to check before ordering.

A foxp1 antibody and the family it shares a domain with

The forkhead box P factors share a conserved DNA binding domain and are co-expressed in several tissues, so a foxp1 antibody raised on that domain reports its relatives too. Splice variants produce several isoforms of different mass, which means the expected bands belong in the method. It is read as a nuclear stain, and a cytoplasmic signal in lymphoid tissue is usually the antibody rather than the biology.

A pax7 antibody and the satellite cell it marks

PAX7 marks quiescent muscle satellite cells and is lost as they differentiate, so a pax7 antibody reads a rare population and the number of positive nuclei per fibre is the measurement. Rarity is what makes the negative control decisive, since raising the gain turns background into cells. The paired box domain is shared across the family, so the clone's specificity against PAX3 in particular has to be stated.

Common questions

Why is my nuclear factor, a NANOG antibody or SOX2 antibody target, absent from the lysate?

Because it is bound to chromatin and stayed in the pellet. Use a nuclear extraction protocol and blot the pellet as well as the supernatant to confirm where the target went.

Are immediate early genes useful as markers?

As activity readouts, yes; as identity markers, no. They respond within minutes to handling, dissociation and medium change, so a difference between groups can be a difference in processing.

How much does retrieval matter?

More than the antibody, for most nuclear targets in fixed tissue. A weak nuclear stain is far more often under-retrieved than under-sensitive.

Browse by service class

• Compare Gene synthesis on advertised prices